{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 5435"}, "official-title": {"#tail": "\n\t", "#text": "To amend title XVIII of the Social Security Act to provide for the coverage of home as a site of\n\t\t\t care for infusion therapy under the Medicare Program."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140910", "#text": "September 10, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such\n\t\t\t provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HWM00", "#text": "Committee on Ways and Means"}], "sponsor": {"#tail": " (for himself, ", "#text": "Mr. Engel", "@name-id": "E000179"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Tiberi", "@name-id": "T000462"}, {"#tail": ", ", "#text": "Mr. Larson of Connecticut", "@name-id": "L000557"}, {"#tail": ", ", "#text": "Mr. Harper", "@name-id": "H001045"}, {"#tail": ", ", "#text": "Mr. Meehan", "@name-id": "M001181"}, {"#tail": ", and ", "#text": "Ms. Pingree of Maine", "@name-id": "P000597"}, {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Peterson", "@name-id": "P000258"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HA8AB4879CFC0422B914437B44B7C249D", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": "\n        ", "@entity-type": "act", "@value": "Medicare Home Infusion Site of Care Act of 2014", "short-title": {"#tail": "\n          ", "#text": "Medicare Home Infusion Site of Care Act of 2014"}, "#text": "\n            "}, "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H491000A8033F43A0B0FF6070E8CD66AB"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "Congress finds the following:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "The Medicare fee-for-service program covers infusion therapy in the hospital, skilled nursing\n\t\t\t facility, physician office, and hospital outpatient department, but does\n\t\t\t not cover the full range of services for the provision of infusion\n\t\t\t therapies in a patient\u2019s home."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H48B64F6F4C4542B6A26F0159DA394F5D", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "The Medicare program is presently the only major health care payer in the United States that does\n\t\t\t not provide comprehensive coverage of home infusion therapy."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H1430ADFA3F0D461F9D5A74E2F705BB42", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "As a result of the Medicare program not providing for comprehensive coverage of home infusion\n\t\t\t therapy, many Medicare beneficiaries are unable to obtain infusion therapy\n\t\t\t in the most cost-effective and convenient setting of their home, and\n\t\t\t physicians are deprived of the ability to select the best site of care for\n\t\t\t their patients."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "HF1CC49499D784E1B9F32C13B86AE9F23", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "The Medicare program is paying for institutional care for the provision of infusion therapy in many\n\t\t\t instances when such institutional care could be avoided if the Medicare\n\t\t\t program provided coverage for home infusion therapy."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "H2430CCB9D7F4462A896ED8BC85714EC5", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " found in a 2010 report that home infusion therapy is utilized\n\t\t\t widely by private payers providing health insurance coverage for\n\t\t\t individuals enrolled under such coverage and that such private payers\n\t\t\t generally are satisfied with the quality of care and the savings they\n\t\t\t achieve through avoided institutionalizations.", "@entity-type": "federal-body", "#text": "Government Accountability Office", "@entity-id": "0500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "H8C0A718E66D540E487BD5701C1BBB250", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "A recent study has reported a potential savings for Medicare if infusion therapies were covered in\n\t\t\t the home site of care."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "HD5FFAD86EC9E4AA88E722119309B4568", "#text": "\n        "}], "#text": "\n      ", "@id": "HEC20C7C7FCD749769590E1C81C24A5BF"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Medicare coverage of home infusion therapy"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1861 of the Social Security Act", "@value": "Social Security Act/s:1861"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395x", "@value": "usc/42/1395x"}, "@parsable-cite": "usc/42/1395x", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "in subsection (s)(2)\u2014"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "HADB2C1CE4E26424C9B6737F63D045A41", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": {"#tail": " at the end of subparagraph (EE);", "#text": "and"}, "#text": "by striking "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HF7AAABC8623C481186E596421A4B2DBF", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": {"#tail": " at the end of subparagraph (FF); and", "#text": "and"}, "#text": "by inserting "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H9FDCCCE56B454BD29EF3B4432C9BB64D", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "by inserting at the end the following new subparagraph:"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "; and"}, "#tail": "\n\t\t\t\t\t", "@id": "HF59D50C2935C474FBBBE7BCA3EDC9224", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "subparagraph": {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "home infusion therapy (as defined in subsection (iii)(1));", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(GG)"}, "#text": "\n                ", "@id": "H6A5C0A98AE3D43FFBAD06FCAAD0E34C7"}}, "#text": "\n            ", "@id": "H6A98C3D2216E4553BDFC033AD9C1DC89"}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by adding at the end the following new subsection:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "other", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "subsection": {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(iii)"}, "header": {"#tail": "\n              ", "#text": "Home Infusion Therapy"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and in coordination with the provision of\n\t\t\t covered infusion drugs under part D. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall establish such\n\t\t\t standards after taking into account the standards commonly used for home\n\t\t\t infusion therapy by Medicare Advantage plans and in the private sector and\n\t\t\t after consultation with all interested stakeholders.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " means the items and services described in paragraph (2) furnished to an individual, who is under\n\t\t\t the care of a physician, which are provided by a qualified home infusion\n\t\t\t therapy supplier under a plan (for furnishing such items and services to\n\t\t\t such individual) established and periodically reviewed by a physician,\n\t\t\t which items and services are provided in an integrated manner in the\n\t\t\t individual\u2019s home in conformance with uniform standards of care\n\t\t\t established by the ", "#text": "home infusion therapy"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "H64475F70B58D43D0AFF568AFDB2C5C3F", "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The items and services described in this paragraph are the following:"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "#text": "\n                ", "@id": "H4393DBBF0A474BD39AA8C5168D16A738", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Professional services, including nursing services (other than nursing services covered as home\n\t\t\t health services), provided in accordance with the plan (including\n\t\t\t administrative, compounding, dispensing, distribution, clinical\n\t\t\t monitoring, and care coordination services) and all necessary supplies and\n\t\t\t equipment (including medical supplies such as sterile tubing and infusion\n\t\t\t pumps)."}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HBEFA8A5FC4C2466BB238862298A6DF59", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines appropriate to administer infusion drug therapies\n\t\t\t to an individual safely and effectively in the home.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Other items and services the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H07BA91399E314440B6CFBCD084A56ED2", "#text": "\n                  "}]}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "For purposes of this subsection:"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "#text": "\n                ", "@id": "HFC3494F3C0D249D4B0F89899CE80F7DD", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "term": {"#tail": " means a place of residence used as an individual\u2019s home and includes such other alternate settings\n\t\t\t as the ", "#text": "home"}, "#text": "The term "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H373498F9CF2D4A47A142727E09023CAB", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means any pharmacy, physician, or other provider licensed by the State in which the pharmacy,\n\t\t\t physician, or provider resides or provides services, whose State\n\t\t\t authorized scope of practice includes dispensing authority and that\u2014", "#text": "qualified home infusion therapy supplier"}, "#text": "The term "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and meets such standards;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "has expertise in the preparation of parenteral medications in compliance with enforceable standards\n\t\t\t of the United States Pharmacopoeia and other nationally recognized\n\t\t\t standards that regulate preparation of parenteral medications as\n\t\t\t determined by the "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H3667B464D85B4B27969D45244196221B", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "provides infusion therapy to patients with acute or chronic conditions requiring parenteral\n\t\t\t administration of drugs and biologicals administered through catheters or\n\t\t\t needles, or both, in a home; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H1BE19583DF2740DFAD3AA0467266349F", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines are necessary to ensure the safe\n\t\t\t and effective provision and administration of home infusion therapy on a\n\t\t\t 7-day-a-week, 24-hour basis (taking into account the standards of care for\n\t\t\t home infusion therapy established by Medicare Advantage plans and in the\n\t\t\t private sector), and the efficient administration of the home infusion\n\t\t\t therapy benefit.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "meets such other uniform requirements as the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "H8D7BEEE4409A4591A70FB21A5E4E0D11", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H58449F92B4D44C74AEB8A77FD1762DC9"}]}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "A qualified home infusion therapy supplier may subcontract with a pharmacy, physician, provider, or\n\t\t\t supplier to meet the requirements of paragraph (3)(B)."}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "#text": "\n                ", "@id": "H8DA154590D174FF8BFD0F54457FAADFB"}], "#text": "\n              ", "@id": "HA6E2622459DE488198CD096F19FC23E2"}, "@other-style": "archaic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H450BA6E591224EE293FECBD727A23A14"}, "#text": "\n          ", "@id": "HEA927BE331754FC49C36E8E4E89D75F6"}], "#text": "\n        ", "@id": "HA497AC83E82B43DC96B7753A3E39349A"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") is amended by adding at the end the\n\t\t\t following new subsection:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1834 of the Social Security Act", "@value": "Social Security Act/s:1834"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395m", "@value": "usc/42/1395m"}, "@parsable-cite": "usc/42/1395m", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Payment for Home Infusion Therapy"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(p)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Payment for home infusion therapy"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall determine a per diem schedule for payment for the professional services\n\t\t\t (including nursing services), supplies, and equipment described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for each infusion therapy type that reflects the\n\t\t\t reasonable costs which must be incurred by efficiently and economically\n\t\t\t operated qualified home infusion therapy suppliers to provide such\n\t\t\t services, supplies, and equipment in conformity with applicable State and\n\t\t\t Federal laws, regulations, and the uniform quality and safety standards\n\t\t\t developed under ", "@entity-type": "act", "#text": "section\n\t\t\t 1861(iii)(2)(A)", "@value": "Social Security Act/s:1861/ss:iii/p:2/sp:A", "@proposed": "true"}, {"#tail": " and to assure that Medicare\n\t\t\t beneficiaries have reasonable access to such therapy.", "@entity-type": "act", "#text": "section 1861(iii)(1)", "@value": "Social Security Act/s:1861/ss:iii/p:1", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "#text": "\n              ", "@id": "HBDA792EFEE444907A91316F154ECE7D3"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall consider recent\n\t\t\t credible studies about the costs of providing infusion therapy in the\n\t\t\t home, consult with home infusion therapy suppliers, consider payment\n\t\t\t amounts established by Medicare Advantage plans and private payers for\n\t\t\t home infusion therapy, and, if necessary, conduct a statistically valid\n\t\t\t national market analysis involving the costs of administering infusion\n\t\t\t drugs and of providing professional services necessary for the drugs\u2019\n\t\t\t administration.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In developing the per diem schedule under this subsection, the "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Considerations"}, "#text": "\n              ", "@id": "H5A9A12EE3AEB4448A701CF77A49B8F5F"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall update such schedule from year to year by the percentage increase in the\n\t\t\t Consumer Price Index for all urban consumers (United States city average)\n\t\t\t for the 12-month period ending with June of the preceding year. The\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may modify the per diem schedule with respect to beneficiaries\n\t\t\t who qualify for home infusion therapy services under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t but who receive nursing services as home health services.", "@entity-type": "act", "#text": "section 1861(iii)(1)", "@value": "Social Security Act/s:1861/ss:iii/p:1", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Annual updates"}, "#text": "\n              ", "@id": "HDEABAFE8C22146289DBC71C55EE60C5E"}], "#text": "\n            ", "@id": "HE94EFC3F35194D63B3BF1531466A3D0B"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H3A9111FFAB364227BBC54D5A6054DDD8"}, "#text": "\n        ", "@id": "HEB19F584F1FC41B88E37CABDF6CE29A7"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Conforming amendments"}, "paragraph": [{"#tail": "\n        ", "@id": "H27B434142D7447CB9C4484F32DFCC891", "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Payment reference"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1833(a)(1) of the Social Security Act", "@value": "Social Security Act/s:1833/ss:a/p:1"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 13951(a)(1)", "@value": "usc/42/13951/a/1"}, "@parsable-cite": "usc/42/13951", "#text": "\n              ", "@legal-doc": "usc"}}}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " before ", "#text": "and"}, {"#tail": "; and", "#text": "\n                (Z)\n              "}], "#text": "by striking "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H1140CA5FB25044958978A5F97405025F", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "section 1834(p)", "@value": "Social Security Act/s:1834/ss:p", "@proposed": "true"}, "#text": ", and (AA) with respect to home infusion therapy, the amounts paid shall be determined under\n\t\t\t "}, "#text": "by inserting before the semicolon at the end the following: "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HFE24208DAD75487299107E987A430EEE", "#text": "\n            "}]}, {"#tail": "\n        ", "@id": "H68245F4A7ECE481FAF6F5890FD640B6B", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Direct payment"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "The first sentence of ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") is\n\t\t\t amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1842(b)(6) of the Social Security Act", "@value": "Social Security Act/s:1842/ss:b/p:6"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395u(b)(6)", "@value": "usc/42/1395u/b/6"}, "@parsable-cite": "usc/42/1395u", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " before ", "#text": "and"}, {"#tail": "; and", "#text": "\n                (H)\n              "}], "#text": "by striking "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H4FDB53F5DBE24C81894D2F975A6B261D", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": {"#tail": ".", "#text": ", and (I) in the case of home infusion therapy, payment shall be made to the qualified home\n\t\t\t infusion therapy supplier"}, "#text": "by inserting before the period at the end the following: "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H87833B5FD17F4F4D9DB1FC9DCC67C72B", "#text": "\n            "}]}, {"#tail": "\n        ", "@id": "HBE6E4A4BEB2641748D0BDED30F0D52DE", "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Exclusion from durable medical equipment and home health services"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1861 of the Social Security Act", "@value": "Social Security Act/s:1861"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395x", "@value": "usc/42/1395x"}, "@parsable-cite": "usc/42/1395x", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "in subsection (m)(5)\u2014"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": [{"#tail": " before ", "#text": "and"}, {"#tail": " and inserting a comma; and", "#text": "durable medical equipment"}], "#text": "by striking "}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "#text": "\n              ", "@id": "H35DD7422B5E44F44A7B07751471C2D54", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": {"#tail": "; and", "#text": ", and supplies used in the provision of home infusion therapy after excluding other drugs and\n\t\t\t biologicals"}, "#text": "by inserting before the semicolon at the end the following: "}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "#text": "\n              ", "@id": "H2F0CA8DEB8B347CDB70D1D8A4A2C4340", "@commented": "no"}], "#text": "\n            ", "@id": "H945EE907287B4349B3EA848F08C081B7", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": {"#tail": ".", "#text": "Such term does not include home infusion therapy, other than equipment and supplies used in the\n\t\t\t provision of insulin."}, "#text": "in subsection (n), by adding at the end the following: "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H45C4738A4981497F86065E6A8DF3999E", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "The provisions of ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") apply to the\n\t\t\t accreditation of qualified home infusion therapy suppliers in the same way\n\t\t\t as they apply to other suppliers.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1865(a) of the Social Security Act", "@value": "Social Security Act/s:1865/ss:a"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395bb(a)", "@value": "usc/42/1395bb/a"}, "@parsable-cite": "usc/42/1395bb", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "header": {"#tail": "\n          ", "#text": "Application of accreditation provisions"}, "#text": "\n          ", "@id": "H395D5BB6233940A8B7392A8D8F2A530F", "@commented": "no"}], "#text": "\n        ", "@id": "HB1C3E6C5FC2442E6818BF8EE5B2EB8E1"}], "#text": "\n      ", "@id": "H8AFA48EF10BD47D58CA5B64201FE06CB"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u20132(e) of the Social Security Act", "@value": "Social Security Act/s:1860D\u20132/ss:e"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013102(e)", "@value": "usc/42/1395w\u2013102/e"}, "@parsable-cite": "usc/42/1395w-102", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "Medicare coverage of home infusion drugs"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "in paragraph (1)\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "#text": "\n        ", "@id": "H4C693BF005774DD0A594984F5F3159C1", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " at the end of subparagraph (A);", "#text": "or"}, "#text": "by striking "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H520BAC1A696046DEB234BBF9B300D315", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": "; and", "#text": "; or"}, "#text": "by striking the comma at the end of subparagraph (B) and inserting, "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "HB9B6DFFE4FB44B1CB97BC894B4D9F2B9", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by inserting after subparagraph (B) the following new subparagraph:"}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "; and"}, "#tail": "\n\t\t\t\t", "@id": "H7BBFD067A5DC4D27906B901D7EAA9DD4", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "subparagraph": {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "an infusion drug (as defined in paragraph (5)),", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(C)"}, "@id": "HA6F198C2291E4F08BCED5C3CF90FC0B0", "#text": "\n              "}}, "#text": "\n          ", "@id": "HBBA114CBF7ED4C22B781ED29A56D1382"}]}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "by adding at the end the following new paragraph:"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"#tail": "\n          ", "text": {"#tail": "\n          ", "term": {"#tail": " means a parenteral drug or biological administered via an intravenous, intraspinal,\n\t\t\t intra-arterial, intrathecal, epidural, subcutaneous, or intramuscular\n\t\t\t access device or injection, and may include a drug used for catheter\n\t\t\t maintenance and declotting, a drug contained in a device, additives\n\t\t\t including but not limited to vitamins, minerals, solutions, and diluents,\n\t\t\t and other components used in the provision of home infusion therapy.", "#text": "infusion drug"}, "#text": "For purposes of this part, the term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(5)"}, "header": {"#tail": "\n            ", "#text": "Infusion drug defined"}, "#text": "\n            ", "@id": "HB0DE9C6A346040388E09EC9716F47D3D"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H2E8AA6A4D1FB4D868E65D970DE46913F"}, "#text": "\n        ", "@id": "H893653100FEB437E812137D0B51465E3"}], "#text": "\n      ", "@id": "H09DE4C05E0B844C99023719132A5AD9F"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n\t\t\t", "#text": "Ensuring beneficiary access to home infusion therapy"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall implement the Medicare home infusion therapy\n\t\t\t benefit under the amendments made by this Act in a manner that ensures\n\t\t\t that Medicare beneficiaries have timely and appropriate access to infusion\n\t\t\t therapy in their homes and that there is rapid and seamless coordination\n\t\t\t between drug coverage under ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": " and coverage for home infusion therapy services under ", "@entity-type": "act", "#text": "part D of title XVIII of the Social Security\n\t\t\t Act", "@value": "Social Security Act/t:XVIII/pt:D"}, {"#tail": " of such\n\t\t\t title to avoid the filing of duplicative or otherwise improper claims.\n\t\t\t Specifically, the ", "@entity-type": "act", "#text": "part B", "@value": "Social Security Act/t:XVIII/pt:B"}, {"#tail": " shall ensure that\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Objectives in implementation"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t consider the use of consolidated claims encompassing covered ", "@entity-parent-id": "7500", "@entity-type": "federal-body", "#text": "Secretary"}, {"#tail": " drugs\n\t\t\t and ", "@entity-type": "act", "#text": "part D", "@value": "Social Security Act/t:XVIII/pt:D"}, {"#tail": " services, supplies, and equipment under such ", "@entity-type": "act", "#text": "part B", "@value": "Social Security Act/t:XVIII/pt:B"}, {"#tail": " to ensure\n\t\t\t the efficient operation of this benefit;", "@entity-type": "act", "#text": "part B", "@value": "Social Security Act/t:XVIII/pt:B"}], "#text": "the benefit is practical and workable with minimal administrative burden for beneficiaries,\n\t\t\t qualified home infusion therapy suppliers, physicians, prescription drug\n\t\t\t plans, MA\u2013PD plans, and Medicare Advantage plans, and the "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H774721558F864DE59B910A82AE3F0A03", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "any prior authorization or utilization review process is expeditious, allowing Medicare\n\t\t\t beneficiaries meaningful access to home infusion therapy;"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H6C420EEDC5534499AA819E9E0C2405B0", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "medical necessity determinations for home infusion therapy will be made\u2014"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "HE40009C5F56B42488894F91DFFA48212", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t and communicated to the appropriate prescription drug plans; or", "@entity-type": "act", "#text": "part B", "@value": "Social Security Act/t:XVIII/pt:B"}, "#text": "except as provided in subparagraph (B), by Medicare administrative contractors under such "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HA470D2A373404164ADFF647908FF7991", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "in the case of an individual enrolled in a Medicare Advantage plan, by the Medicare Advantage\n\t\t\t organization offering the plan; and an individual may be initially\n\t\t\t qualified for coverage for such benefit for a 90-day period and subsequent\n\t\t\t 90-day periods thereafter;"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HBBCF1228E90E4E128E9A35A590413037", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "except as otherwise provided in this section, the benefit is modeled on current private sector\n\t\t\t coverage and coding for home infusion therapy; and"}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H0F72CA5F41EB4C7AA39A64F2DAA74547", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "prescription drug plans and MA\u2013PD plans structure their formularies, utilization review protocols,\n\t\t\t and policies in a manner that ensures that Medicare beneficiaries have\n\t\t\t timely and appropriate access to infusion therapy in their homes."}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "H8EE0B333AED6435FA2BDFA544D613F96", "#text": "\n          "}], "#text": "\n        ", "@id": "H594A02A011724C6B82D3DAF096C806B5"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit a report\n\t\t\t to ", "@entity-type": "federal-body", "#text": "Comptroller General of the United States", "@entity-id": "0500"}, {"#tail": " on Medicare beneficiary access to home infusion therapy. Such\n\t\t\t report shall specifically address whether the objectives specified in\n\t\t\t subsection (a) have been met and shall make recommendations to ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": "\n\t\t\t and the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " on how to improve the\n\t\t\t benefit and better ensure that Medicare beneficiaries have timely and\n\t\t\t appropriate access to infusion therapy in their homes.", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}], "#text": "Not later than January 1, 2018, the "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Report"}, "#text": "\n        ", "@id": "H32FF7D10F9B2479F93BD60E7D83CA670"}], "#text": "\n      ", "@id": "HB4B689C8A19F4808978326DEEDFCEC80"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t", "#text": "The amendments made by this Act shall apply to home infusion therapy furnished on or after January\n\t\t\t 1, 2015.", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n      ", "#text": "Effective date"}, "#text": "\n      ", "@id": "HCBD8654BC80B4CC2BE35A601970BC0F3"}], "#text": "\n\t\t", "@id": "HFB4CCE126237471992856ACDD558396F"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-09-10"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 5435 IH: Medicare Home Infusion Site of Care Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}